ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Senores Pharmaceuticals held its 9th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, director appointments, and the new Employee Stock Option Scheme 2026.
Senores Pharmaceuticals Ltd submitted its Annual Report for FY 2025-26 and notice for its 9th Annual General Meeting scheduled for September 25, 2026.
Senores Pharmaceuticals Ltd informed the exchange that shareholders approved ordinary and special resolutions via postal ballot, including related party transactions and loan limit enhancements.
Senores Pharmaceuticals has issued a Postal Ballot Notice to shareholders for approval of related party transactions. Voting concludes August 3, 2026, with results announced by August 5.